- Home
- NOVT vs SLNO Comparison
NOVT vs SLNO Comparison
Compare NOVT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOVT
- SLNO
- Stock Information
- Founded
- NOVT 1968
- SLNO 1999
- Country
- NOVT United States
- SLNO United States
- Employees
- NOVT N/A
- SLNO N/A
- Industry
- NOVT Industrial Machinery/Components
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NOVT Miscellaneous
- SLNO Health Care
- Exchange
- NOVT Nasdaq
- SLNO Nasdaq
- Market Cap
- NOVT 4.2B
- SLNO 3.8B
- IPO Year
- NOVT N/A
- SLNO 2014
- Fundamental
- Price
- NOVT $113.78
- SLNO $51.17
- Analyst Decision
- NOVT Hold
- SLNO Strong Buy
- Analyst Count
- NOVT 1
- SLNO 10
- Target Price
- NOVT $133.00
- SLNO $112.50
- AVG Volume (30 Days)
- NOVT 326.9K
- SLNO 1.7M
- Earning Date
- NOVT 11-04-2025
- SLNO 11-05-2025
- Dividend Yield
- NOVT N/A
- SLNO N/A
- EPS Growth
- NOVT N/A
- SLNO N/A
- EPS
- NOVT 1.69
- SLNO N/A
- Revenue
- NOVT $956,880,000.00
- SLNO $32,656,999.00
- Revenue This Year
- NOVT $5.06
- SLNO N/A
- Revenue Next Year
- NOVT $6.89
- SLNO $175.39
- P/E Ratio
- NOVT $67.48
- SLNO N/A
- Revenue Growth
- NOVT 6.34
- SLNO N/A
- 52 Week Low
- NOVT $98.76
- SLNO $41.50
- 52 Week High
- NOVT $184.11
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- NOVT 43.80
- SLNO 23.27
- Support Level
- NOVT $113.34
- SLNO $50.63
- Resistance Level
- NOVT $118.30
- SLNO $72.99
- Average True Range (ATR)
- NOVT 2.86
- SLNO 4.38
- MACD
- NOVT 0.11
- SLNO -1.38
- Stochastic Oscillator
- NOVT 41.01
- SLNO 2.42
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.